Insider Trading & Ownership of PERCEPTIVE ADVISORS LLC

Location: New York, NY
Summary: The estimated value of insider holdings of PERCEPTIVE ADVISORS LLC is at least $1,024,329,777 dollars as of 18 Mar 2026. PERCEPTIVE ADVISORS LLC is the 10%+ Owner of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $200.34M. PERCEPTIVE ADVISORS LLC is the 10%+ Owner of VBI Vaccines Inc/BC and owns shares of VBI Vaccines Inc/BC stock worth about $137.17M. PERCEPTIVE ADVISORS LLC is the 10%+ Owner of SOLENO THERAPEUTICS INC and owns shares of SOLENO THERAPEUTICS INC (SLNO) stock worth about $112.18M. PERCEPTIVE ADVISORS LLC is the Director of Immatics N.V. and owns shares of Immatics N.V. (IMTX) stock worth about $102.8M. PERCEPTIVE ADVISORS LLC is the Director, 10%+ Owner of MeiraGTx Holdings plc and owns shares of MeiraGTx Holdings plc (MGTX) stock worth about $93.42M. PERCEPTIVE ADVISORS LLC is the 10%+ Owner of ALBIREO PHARMA, INC. and owns shares of ALBIREO PHARMA, INC. stock worth about $84.96M. PERCEPTIVE ADVISORS LLC is the Director of Astria Therapeutics, Inc. and owns shares of Astria Therapeutics, Inc. stock worth about $67.17M. PERCEPTIVE ADVISORS LLC is the 10%+ Owner of ADMA BIOLOGICS, INC. and owns shares of ADMA BIOLOGICS, INC. (ADMA) stock worth about $59.95M. PERCEPTIVE ADVISORS LLC is the 10%+ Owner of Verrica Pharmaceuticals Inc. and owns shares of Verrica Pharmaceuticals Inc. (VRCA) stock worth about $51.4M. PERCEPTIVE ADVISORS LLC is the 10%+ Owner of Aldeyra Therapeutics, Inc. and owns shares of Aldeyra Therapeutics, Inc. (ALDX) stock worth about $27.83M. PERCEPTIVE ADVISORS LLC is the 10%+ Owner of Orchestra BioMed Holdings, Inc. and owns shares of Orchestra BioMed Holdings, Inc. (OBIO) stock worth about $18.68M. PERCEPTIVE ADVISORS LLC is the 10%+ Owner of AGILE THERAPEUTICS INC and owns shares of AGILE THERAPEUTICS INC stock worth about $18.41M. PERCEPTIVE ADVISORS LLC is the Director, 10%+ Owner of Athira Pharma, Inc. and owns shares of LeonaBio, Inc. (LONA) stock worth about $17.72M. PERCEPTIVE ADVISORS LLC is the 10%+ Owner of VYNE Therapeutics Inc. and owns shares of VYNE Therapeutics Inc. (VYNE) stock worth about $11.25M. PERCEPTIVE ADVISORS LLC is the Former 10% Owner of CARGO Therapeutics, Inc. and owns shares of CARGO Therapeutics, Inc. stock worth about $5M. PERCEPTIVE ADVISORS LLC is the 10%+ Owner of Acrivon Therapeutics, Inc. and owns shares of Acrivon Therapeutics, Inc. (ACRV) stock worth about $4.16M. PERCEPTIVE ADVISORS LLC is the Director, 10%+ Owner of Adagio Medical Holdings, Inc. and owns shares of Adagio Medical Holdings, Inc. (ADGM) stock worth about $3.51M. PERCEPTIVE ADVISORS LLC is the 10%+ Owner of Rain Therapeutics Inc. and owns shares of Rain Oncology Inc. stock worth about $3.01M. PERCEPTIVE ADVISORS LLC is the 10%+ Owner of IsoPlexis Corp and owns shares of IsoPlexis Corp stock worth about $2.97M. PERCEPTIVE ADVISORS LLC is the 10%+ Owner of CHEMBIO DIAGNOSTICS, INC. and owns shares of CHEMBIO DIAGNOSTICS, INC. stock worth about $1.65M. PERCEPTIVE ADVISORS LLC is the 10%+ Owner of Quotient Ltd and owns shares of Quotient Ltd stock worth about $635.6K. PERCEPTIVE ADVISORS LLC is the Director, 10%+ Owner of LianBio and owns shares of LianBio (LIANY) stock worth about $81.3K. PERCEPTIVE ADVISORS LLC is the 10%+ Owner of Lyra Therapeutics, Inc. and owns shares of Lyra Therapeutics, Inc. (LYRA) stock worth about $54.7K.
Signature: /s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
All Insider Reports: All Insider Reports

Follow Filing Activity

Follow PERCEPTIVE ADVISORS LLC and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

PERCEPTIVE ADVISORS LLC has 29 issuer positions tracked on this page.
Estimated disclosed ownership value: $1,024,329,777.
Recent insider filing activity is available below.

Change

Largest disclosed position: Crinetics Pharmaceuticals, Inc. ($200,336,855).
Past-year value change for that position: .

Research use

This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
You can cross-check role, issuer, and filing chronology directly against the SEC source.